Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and Vitamin E in Fragile X Syndrome
NCT02942498Phase 3Completed
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid, tocopherol in Fragile X syndrome (FXS). Started Jul 2016; status: completed.
02
Drugs
ascorbic acidtocopherol
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT02942498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942498.